197 related articles for article (PubMed ID: 22045867)
1. Potentiation of aspirin-induced cerebroprotection by minocycline: a therapeutic approach to attenuate exacerbation of transient focal cerebral ischaemia.
Bhatt LK; Addepalli V
Diab Vasc Dis Res; 2012 Jan; 9(1):25-34. PubMed ID: 22045867
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of matrix metalloproteinase 2 and 9 inhibitory action of minocycline by aspirin: an approach to attenuate outcome of acute myocardial infarction in diabetes.
Bhatt LK; Veeranjaneyulu A
Arch Med Res; 2014 Apr; 45(3):203-9. PubMed ID: 24606818
[TBL] [Abstract][Full Text] [Related]
3. A therapeutic approach to treat cardiovascular dysfunction of diabetes.
Bhatt LK; Veeranjaneyulu A
Exp Toxicol Pathol; 2012 Nov; 64(7-8):847-53. PubMed ID: 21474293
[TBL] [Abstract][Full Text] [Related]
4. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase.
Nagel S; Su Y; Horstmann S; Heiland S; Gardner H; Koziol J; Martinez-Torres FJ; Wagner S
Brain Res; 2008 Jan; 1188():198-206. PubMed ID: 18031717
[TBL] [Abstract][Full Text] [Related]
5. Minocycline with aspirin: a therapeutic approach in the treatment of diabetic neuropathy.
Bhatt LK; Veeranjaneyulu A
Neurol Sci; 2010 Dec; 31(6):705-16. PubMed ID: 20213226
[TBL] [Abstract][Full Text] [Related]
6. Minocycline with aspirin: an approach to attenuate diabetic nephropathy in rats.
Kumar Bhatt L; Addepalli V
Ren Fail; 2011; 33(1):72-8. PubMed ID: 21219209
[TBL] [Abstract][Full Text] [Related]
7. Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats.
Hung YC; Chen TY; Lee EJ; Chen WL; Huang SY; Lee WT; Lee MY; Chen HY; Wu TS
J Pineal Res; 2008 Nov; 45(4):459-67. PubMed ID: 18624955
[TBL] [Abstract][Full Text] [Related]
8. Diphenyleneiodonium and dimethylsulfoxide for treatment of reperfusion injury in cerebral ischemia of the rat.
Nagel S; Genius J; Heiland S; Horstmann S; Gardner H; Wagner S
Brain Res; 2007 Feb; 1132(1):210-7. PubMed ID: 17184751
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia.
Hosomi N; Ban CR; Naya T; Takahashi T; Guo P; Song XY; Kohno M
J Cereb Blood Flow Metab; 2005 Aug; 25(8):959-67. PubMed ID: 15729288
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia.
Hosomi N; Nishiyama A; Ban CR; Naya T; Takahashi T; Kohno M; Koziol JA
Neuroscience; 2005; 134(1):225-31. PubMed ID: 15963646
[TBL] [Abstract][Full Text] [Related]
11. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
Pfefferkorn T; Rosenberg GA
Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
[TBL] [Abstract][Full Text] [Related]
12. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
13. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
Allahtavakoli M; Amin F; Esmaeeli-Nadimi A; Shamsizadeh A; Kazemi-Arababadi M; Kennedy D
Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606
[TBL] [Abstract][Full Text] [Related]
14. Aspirin attenuates cerebral ischemic injury in diabetic rats.
Wang T; Fu FH; Han B; Zhu M; Yu X; Zhang LM
Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):181-5. PubMed ID: 19053022
[TBL] [Abstract][Full Text] [Related]
15. Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia.
Tai SH; Chen HY; Lee EJ; Chen TY; Lin HW; Hung YC; Huang SY; Chen YH; Lee WT; Wu TS
J Pineal Res; 2010 Nov; 49(4):332-41. PubMed ID: 20663046
[TBL] [Abstract][Full Text] [Related]
16. Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats.
Fan X; Lo EH; Wang X
Stroke; 2013 Mar; 44(3):745-52. PubMed ID: 23422086
[TBL] [Abstract][Full Text] [Related]
17. Involvement of matrix metalloproteinases-2 and -9 in the formation of a lacuna-like cerebral cavity.
Cayabyab FS; Gowribai K; Walz W
J Neurosci Res; 2013 Jul; 91(7):920-33. PubMed ID: 23606560
[TBL] [Abstract][Full Text] [Related]
18. 17beta-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats.
Liu R; Wen Y; Perez E; Wang X; Day AL; Simpkins JW; Yang SH
Brain Res; 2005 Oct; 1060(1-2):55-61. PubMed ID: 16212944
[TBL] [Abstract][Full Text] [Related]
19. Quercetin reduces the elevated matrix metalloproteinases-9 level and improves functional outcome after cerebral focal ischemia in rats.
Lee JK; Kwak HJ; Piao MS; Jang JW; Kim SH; Kim HS
Acta Neurochir (Wien); 2011 Jun; 153(6):1321-9; discussion 1329. PubMed ID: 21120545
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of acute stroke injury in rat brain by minocycline promotes blood-brain barrier remodeling and alternative microglia/macrophage activation during recovery.
Yang Y; Salayandia VM; Thompson JF; Yang LY; Estrada EY; Yang Y
J Neuroinflammation; 2015 Feb; 12():26. PubMed ID: 25889169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
